PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline. Tew WP, Lacchetti C, Ellis A, Maxian K, et al. J Clin Oncol 2020 Aug 13:JCO2001924. doi: 10.1200/JCO.20.01924.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tew WP, Lacchetti C, Ellis A, Maxian K, et al. PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline. J Clin Oncol 2020 Aug 13:JCO2001924. doi: 10.1200/JCO.20.01924.
PMID: 32790492